CA2033176A1 - Proteines de fusion d'hormones de croissance - Google Patents

Proteines de fusion d'hormones de croissance

Info

Publication number
CA2033176A1
CA2033176A1 CA2033176A CA2033176A CA2033176A1 CA 2033176 A1 CA2033176 A1 CA 2033176A1 CA 2033176 A CA2033176 A CA 2033176A CA 2033176 A CA2033176 A CA 2033176A CA 2033176 A1 CA2033176 A1 CA 2033176A1
Authority
CA
Canada
Prior art keywords
growth hormone
growth
polypeptide
fusion proteins
fusion protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2033176A
Other languages
English (en)
Other versions
CA2033176C (fr
Inventor
Julian Richard Este Wells
Robert Michael King
Geoffrey Leonard Francis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novozymes Biopharma DK AS
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2033176A1 publication Critical patent/CA2033176A1/fr
Application granted granted Critical
Publication of CA2033176C publication Critical patent/CA2033176C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/465—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from birds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention se rapporte à un plasmide codant pour une protéine de fusion, comprenant un premier polypeptide produisant une activité d'hormone de croissance et un second polypeptide, lequel peut être constitué par un polypeptide du facteur de croissance d'insuline (IGF)-I ou IGF-II et de leurs analogues, de l'histone de poulet H2A.I ou des facteurs de transcription humaine SPI-Lac Z, une séquence de clivage optionnelle pouvant être placée entre le premier et le seocnd polypeptide. Cette protéine de fusion peut être utilisée: 1) pour traiter des déficiences de l'hormone de croissance; 2) pour supprimer les pertes de protéines corporelles à la suite d'un trauma, tel que brûlures ou infections; 3) pour augmenter les taux de croissance et l'efficacité de la transformation des aliments chez les animaux d'élevage; et 4) pour soutenir la croissance de cellules en culture.
CA002033176A 1989-06-09 1990-05-22 Proteines de fusion d'hormones de croissance Expired - Lifetime CA2033176C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPJ4672 1989-06-09
AUPJ467289 1989-06-09
PCT/AU1990/000210 WO1990015142A1 (fr) 1989-06-09 1990-05-22 Proteines de fusion pour hormones de croissance

Publications (2)

Publication Number Publication Date
CA2033176A1 true CA2033176A1 (fr) 1990-12-10
CA2033176C CA2033176C (fr) 1999-12-14

Family

ID=3773983

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002033176A Expired - Lifetime CA2033176C (fr) 1989-06-09 1990-05-22 Proteines de fusion d'hormones de croissance

Country Status (6)

Country Link
US (1) US5330971A (fr)
EP (1) EP0429586B1 (fr)
AT (1) ATE125869T1 (fr)
CA (1) CA2033176C (fr)
DE (1) DE69021335T2 (fr)
WO (1) WO1990015142A1 (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5977307A (en) * 1989-09-07 1999-11-02 Alkermes, Inc. Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins
CA2074166C (fr) * 1990-02-13 2003-11-25 Francis J. Ballard Methode de traitement de maladies intestinales
US5679771A (en) * 1990-02-13 1997-10-21 Gropep Pty. Ltd. Method for treating intestinal diseases
US5210017A (en) * 1990-11-19 1993-05-11 Genentech, Inc. Ligand-mediated immunofunctional hormone binding protein assay method
FR2686899B1 (fr) * 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
ES2257734T3 (es) * 1992-05-18 2006-08-01 Genentech, Inc. Activacion de los receptores de oligomerizacion por medio de los ligandos de receptores fusionados.
US5684136A (en) * 1992-05-18 1997-11-04 Genentech, Inc. Chimeric hepatocyte growth factor (HGF) ligand variants
NZ260309A (en) * 1992-06-08 1997-07-27 Pharmacia Ab Substituted For K Use of 1gf-2 for prevention or treatment of nutritional or gastrointestinal disorders and promoting neonatal growth
CA2114419A1 (fr) * 1992-06-08 1993-12-23 Peter D. Gluckman Utilisation des facteurs de croissance igf-i et/ou igf-ii
US5444045A (en) * 1992-09-17 1995-08-22 Gropep, Pty. Ltd. Method of administering IGF-1, IGF-2, and analogs thereof to birds
WO1995013290A1 (fr) * 1993-11-12 1995-05-18 North Shore University Hospital Research Corporation Methode pour traiter la dystrophie musculaire
GB9526733D0 (en) * 1995-12-30 1996-02-28 Delta Biotechnology Ltd Fusion proteins
AU757658B2 (en) * 1998-03-09 2003-02-27 Zealand Pharma A/S Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
AUPP298498A0 (en) * 1998-04-17 1998-05-07 Gropep Pty Ltd Matrix binding factor
AU1805200A (en) * 1998-12-10 2000-06-26 Samyang Genex Corporation Method of separating basic peptide or basic protein
AUPQ387599A0 (en) 1999-11-05 1999-12-02 Metabolic Pharmaceuticals Limited Product and method for control of obesity
CN1296974A (zh) * 1999-11-23 2001-05-30 上海博容基因开发有限公司 一种新的多肽——人组蛋白h2a.21和编码这种多肽的多核苷酸
EP1274720A4 (fr) * 2000-04-12 2004-08-18 Human Genome Sciences Inc Proteines fusionnees a l'albumine
US6946134B1 (en) 2000-04-12 2005-09-20 Human Genome Sciences, Inc. Albumin fusion proteins
AU2002239560B2 (en) * 2000-11-28 2006-03-02 Premacure Ab Determination of risk and treatment of complications of prematurity
US20050054051A1 (en) * 2001-04-12 2005-03-10 Human Genome Sciences, Inc. Albumin fusion proteins
US20060084794A1 (en) * 2001-04-12 2006-04-20 Human Genome Sciences, Inc. Albumin fusion proteins
US20050244931A1 (en) * 2001-04-12 2005-11-03 Human Genome Sciences, Inc. Albumin fusion proteins
US7507413B2 (en) 2001-04-12 2009-03-24 Human Genome Sciences, Inc. Albumin fusion proteins
WO2003030821A2 (fr) * 2001-10-05 2003-04-17 Human Genome Sciences, Inc. Proteines de fusion d'albumine
PT1463751E (pt) 2001-12-21 2013-08-26 Human Genome Sciences Inc Proteínas de fusão de albumina
CA2513213C (fr) 2003-01-22 2013-07-30 Human Genome Sciences, Inc. Proteines hybrides d'albumine
US7355018B2 (en) 2003-09-30 2008-04-08 Regeneron Pharmaceuticals, Inc. Modified IGF1 polypeptides with increased stability and potency
AU2006203882B2 (en) 2005-01-07 2011-05-12 Regeneron Pharmaceuticals, Inc. IGF-1 fusion polypeptides and therapeutic uses thereof
US20080103457A1 (en) * 2005-01-11 2008-05-01 Heart Failure Technologies, Inc. University Enterprise Laboratories (Uel) Method and System for Treating Heart Failure
WO2007068053A1 (fr) * 2005-12-15 2007-06-21 Gropep Limited Production de protéines par voie recombinante
WO2008035230A2 (fr) * 2006-09-18 2008-03-27 Novozymes Gropep Limited Compositions protéiques liquides
EP3129463B1 (fr) 2014-04-10 2021-05-26 Bayer Healthcare LLC Formulation de poudre sèche et procédé pour preparer un milieu liquide de culture cellulaire
DK3344758T3 (da) 2015-09-01 2021-11-01 Ncardia B V Fremgangsmåde in vitro til differentiering af en human pluripotent stamcellepopulation i en kardiomyocytcellepopulation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK108685A (da) * 1984-03-19 1985-09-20 Fujisawa Pharmaceutical Co Vaekstfaktor i
US5028531A (en) * 1984-03-19 1991-07-02 Fujisawa Pharmaceutical Company, Ltd. IGF-I fusion proteins; protection of IGF-I from degradation by host cell; and processes for the production thereof
ATE81779T1 (de) * 1985-08-22 1992-11-15 Gropep Pty Ltd Peptidanalogedes insulinaehnlichen wachstumsfaktors-1 bei saeugetieren.
AU613876B2 (en) * 1986-10-01 1991-08-15 Merck & Co., Inc. Synthetic genes encoding proteins from plasmid containing eucaryotic secretory signal peptides and process for secreting encoded proteins
FR2619719B1 (fr) * 1987-09-01 1991-05-10 Sanofi Sa Procede d'obtention d'interleukine-2 a partir de cellules eucaryotes, vecteurs necessaires a sa mise en oeuvre et lignees cellulaires hautement productrices
JPH01144981A (ja) * 1987-12-02 1989-06-07 Wakunaga Pharmaceut Co Ltd 蛋白質の製造
JP2507106B2 (ja) * 1987-12-24 1996-06-12 グロペップ プロプライエタリー リミテッド インスリン様成長因子１（ｉｇｆ―１）または因子２（ｉｇｆ―２）の類縁ペプチド

Also Published As

Publication number Publication date
EP0429586A4 (en) 1992-07-08
DE69021335T2 (de) 1996-04-11
EP0429586B1 (fr) 1995-08-02
WO1990015142A1 (fr) 1990-12-13
ATE125869T1 (de) 1995-08-15
CA2033176C (fr) 1999-12-14
EP0429586A1 (fr) 1991-06-05
DE69021335D1 (de) 1995-09-07
US5330971A (en) 1994-07-19

Similar Documents

Publication Publication Date Title
EP0429586A4 (en) Growth hormone fusion proteins
AU3065989A (en) Polypeptide compounds having growth hormone releasing activity
EP0161640A3 (fr) Cellules de souris enkystées et transformées avec l'ADN rétrovirus aviaire-hormone de croissance bovine et un procédé pour administrer la BGH in vivo
IE863042L (en) Mammalian interleukin-4
IE811463L (en) Interferons
DE69020335D1 (de) B-ketten-analoge des von blutplättchen abstammenden wachstumsfaktors und verfahren zu deren homogener herstellung.
EP0216742A3 (fr) Facteurs de croissance
DE3570579D1 (en) Non-dusty blends of meals or flours with additives for use in fodder production
AU7681687A (en) Expression of platelet-derived growth factor and analogues
AU601959B2 (en) GM-CSF protein, its derivatives, the preparation of proteins of this type, and their use
AU2308992A (en) Cysteine depleted il-6 muteins
EP0111814A3 (fr) Clonage et expression de séquences de nucléotides codant pour l'hormone de croissance bovine
EP0181634A3 (fr) Gène synthétique pour lysozyme humaine
IE871871L (en) Cloning and expression of acidic fibroblast growth factor
EP0287075A3 (en) Process for the construction of an animal cell line for the production of human beta-interferon
WO1993018163A3 (fr) Apport et expression d'une proteine de surface hybride sur la surface de bacteries gram positif
NZ235743A (en) Food additives promoting ice nucleation containing proteins carried by gras microorganisms, plasmids and recombinant host cells
AU590861B2 (en) New human lymphotoxin (TNF-beta) polypeptides their prepartion and use
EP0276778A3 (fr) Expression à haut niveau de IL-1bêta soluble et mature dans E. coli et dérivés ayant une activité biologique modifiée
HK65691A (en) Cell growth regulatory factor
SE9403055D0 (sv) A new human peptide antibiotic (FALL-39) and its use
MY100892A (en) Veterinary preparations.
AU2140695A (en) Recombinant viruses coding for a glutamate decarboxylase (gad) activity
CA2089111A1 (fr) Agent mitogene des muscles lisses et adn isole l'encodant
ZA95968B (en) Interferon alpha/beta binding protein its preparation and use

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry